UDR vs AMH vs ELS
161 measures in 16 categories, one definition each, computed from filings and market data.
AMH56.3
American Homes 4 Rent
Real Estate · REIT - Residential
$31.28 +1.03%$11.2B mkt cap
Score DNA
ELS67.3
Equity LifeStyle Properties, Inc.
Real Estate · REIT - Residential
$61.21 +1.59%$11.9B mkt cap
Score DNA
Price, rebased to 100 three years ago
UDR AMH ELS · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | UDR | AMH | ELS |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 24 | 0 |
| Insider $ bought, 180d | — | $0.64M | — |
| Congress purchases, 180d | 1 | 0 | 0 |
| Last Congress purchase | 2026-03-27 | — | — |
| 13F net change in holders | −1 | +25 | −14 |
| ETFs adding shares, 30d | 526 | 296 | 354 |
| ETFs trimming, 30d | 484 | 275 | 314 |
| Net ETF funds, 30d | +42 | +21 | +40 |
Valuation
16 measures| Measure | UDR | AMH | ELS |
|---|---|---|---|
| P/E (TTM) | 21.1x
11th
|
23.5x
22nd
|
29.6x
44th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 3.45
100th
|
2.56
50th
|
2.65
75th
|
| Price / sales | 6.4x
75th
|
6.0x
50th
|
7.5x
92nd
|
| Price / book | 3.7x
92nd
|
1.7x
33rd
|
6.8x
100th
|
| Price / tangible book | 4.4x
92nd
|
1.8x
33rd
|
7.3x
100th
|
| Price / free cash flow | 11.9x
17th
|
12.1x
25th
|
22.7x
75th
|
| Price / operating cash flow | 12.4x
33rd
|
13.0x
50th
|
20.2x
100th
|
| Enterprise value | $17.0B
67th
|
$16.3B
58th
|
$15.2B
50th
|
| EV / sales | 9.9x
92nd
|
8.7x
58th
|
9.6x
83rd
|
| EV / EBITDA | 12.9x
17th
|
13.6x
33rd
|
24.2x
100th
|
| EV / EBIT | 26.2x
36th
|
23.7x
18th
|
36.4x
73rd
|
| EV / free cash flow | 18.4x
17th
|
17.6x
8th
|
29.0x
67th
|
| Earnings yield | 4.7%
92nd
|
4.3%
83rd
|
3.4%
67th
|
| FCF yield | 8.4%
83rd
|
8.2%
75th
|
4.4%
25th
|
| Operating cash flow yield | 8.1%
67th
|
7.7%
50th
|
5.0%
0th
|
| Graham number (per share) | $18.06
22nd
|
$23.61
56th
|
$19.92
44th
|
Profitability (TTM)
12 measures| Measure | UDR | AMH | ELS |
|---|---|---|---|
| Gross margin | 55.7%
75th
|
30.6%
17th
|
43.3%
33rd
|
| EBITDA margin | 76.8%
91st
|
63.6%
64th
|
39.5%
9th
|
| Operating margin | 28.2%
58th
|
25.3%
42nd
|
35.7%
92nd
|
| EBIT margin | 37.9%
91st
|
36.6%
82nd
|
26.2%
36th
|
| Net margin | 30.4%
92nd
|
25.5%
83rd
|
25.3%
75th
|
| NOPAT margin | 28.2%
67th
|
25.2%
42nd
|
36.0%
92nd
|
| FCF margin | 53.7%
91st
|
49.3%
82nd
|
32.9%
45th
|
| Operating cash flow margin | 51.9%
91st
|
46.0%
73rd
|
37.1%
27th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 5.3%
58th
|
3.5%
17th
|
2.8%
0th
|
| Stock comp / revenue | 1.6%
92nd
|
1.3%
67th
|
0.4%
25th
|
| Effective tax rate | 0.2%
42nd
|
0.6%
50th
|
-0.8%
0th
|
Returns on capital
11 measures| Measure | UDR | AMH | ELS |
|---|---|---|---|
| ROE (on average equity) | 16.7%
92nd
|
6.8%
42nd
|
23.0%
100th
|
| ROA | 5.0%
83rd
|
3.6%
75th
|
7.0%
100th
|
| ROIC | 5.4%
83rd
|
4.0%
33rd
|
11.4%
100th
|
| ROCE | 7.3%
83rd
|
5.5%
50th
|
7.4%
92nd
|
| Return on tangible assets | 6.2%
75th
|
5.2%
33rd
|
7.2%
83rd
|
| Cash ROIC (OCF / invested capital) | 10.0%
83rd
|
7.3%
42nd
|
11.7%
92nd
|
| Gross profitability (GP / assets) | 9.3%
67th
|
4.4%
17th
|
11.9%
92nd
|
| ROIC, 3-yr average | 2.8%
36th
|
3.6%
64th
|
9.0%
100th
|
| ROIC, 5-yr average | 2.9%
36th
|
3.4%
64th
|
8.0%
100th
|
| ROE, 5-yr average | 8.1%
64th
|
5.4%
55th
|
21.6%
100th
|
| Incremental ROIC | -101.3%
8th
|
-12.7%
25th
|
216.6%
92nd
|
Growth
17 measures| Measure | UDR | AMH | ELS |
|---|---|---|---|
| Revenue growth (TTM YoY) | 1.5%
42nd
|
4.5%
58th
|
9.6%
92nd
|
| Revenue growth (QoQ) | -0.1%
17th
|
-0.4%
8th
|
0.0%
25th
|
| Revenue CAGR, 3 yr | 2.5%
55th
|
6.3%
82nd
|
3.6%
64th
|
| Revenue CAGR, 5 yr | 7.0%
45th
|
8.8%
91st
|
6.1%
36th
|
| Gross profit CAGR, 3 yr | 36.6%
100th
|
-12.2%
18th
|
-0.6%
55th
|
| Operating income CAGR, 3 yr | -7.6%
27th
|
-15.2%
18th
|
12.6%
91st
|
| Net income growth (TTM YoY) | 295.8%
100th
|
12.2%
44th
|
9.3%
33rd
|
| Net income CAGR, 3 yr | 5.3%
43rd
|
9.2%
57th
|
12.1%
71st
|
| EPS growth (TTM YoY) | 303.4%
100th
|
14.8%
44th
|
9.2%
33rd
|
| EPS CAGR, 3 yr | 6.1%
43rd
|
9.2%
57th
|
11.2%
71st
|
| EPS CAGR, 5 yr | 97.0%
100th
|
20.0%
62nd
|
8.7%
50th
|
| FCF growth (TTM YoY) | 55.0%
91st
|
32.8%
73rd
|
49.0%
82nd
|
| FCF CAGR, 3 yr | 20.3%
80th
|
19.0%
60th
|
45.1%
100th
|
| Operating cash flow CAGR, 3 yr | 2.3%
45th
|
7.2%
82nd
|
7.1%
73rd
|
| Book value CAGR, 3 yr | -10.0%
18th
|
-0.3%
82nd
|
6.2%
100th
|
| Dividend CAGR, 3 yr | -92.6%
0th
|
3.5%
82nd
|
1.5%
64th
|
| Sustainable growth rate | 16.7%
100th
|
0.0%
78th
|
-0.7%
44th
|
Margin history & stability
7 measures| Measure | UDR | AMH | ELS |
|---|---|---|---|
| Gross margin, 3-yr average | 35.5%
0th
|
47.2%
36th
|
47.0%
27th
|
| Operating margin, 3-yr average | 22.5%
36th
|
39.9%
100th
|
28.6%
64th
|
| Net margin, 3-yr average | 15.5%
45th
|
23.7%
82nd
|
25.4%
91st
|
| FCF margin, 3-yr average | 40.5%
82nd
|
42.9%
91st
|
27.1%
18th
|
| Revenue stability (0-1) | 0.85
55th
|
0.98
73rd
|
0.89
64th
|
| Earnings stability (0-1) | 0.33
64th
|
0.94
82nd
|
0.96
91st
|
| Margin stability (0-1) | 0.48
9th
|
0.78
36th
|
0.94
82nd
|
Liquidity (latest quarter)
7 measures| Measure | UDR | AMH | ELS |
|---|---|---|---|
| Cash & short-term investments | $1.2M
0th
|
$83.7M
83rd
|
$35.6M
42nd
|
| Net cash (− = net debt) | −$6.0B
17th
|
−$5.1B
33rd
|
−$3.3B
58th
|
| Working capital | −$1.2B
0th
|
$312.2M
83rd
|
−$150.8M
25th
|
| Current ratio | 0.15
9th
|
1.61
64th
|
0.31
27th
|
| Quick ratio | 0.15
9th
|
1.61
64th
|
0.31
27th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.00
0th
|
0.16
25th
|
0.16
33rd
|
| Defensive interval (days) | 134 days
30th
|
473 days
90th
|
202 days
50th
|
Leverage & solvency (latest quarter)
13 measures| Measure | UDR | AMH | ELS |
|---|---|---|---|
| Total debt | $6.0B
83rd
|
$5.1B
67th
|
$3.3B
42nd
|
| Debt / equity | 2.04
92nd
|
0.76
25th
|
1.88
83rd
|
| Net debt / equity | 2.04
92nd
|
0.74
25th
|
1.86
83rd
|
| Debt / assets | 58.4%
92nd
|
39.3%
17th
|
57.1%
83rd
|
| Debt / capital | 67.1%
92nd
|
43.1%
25th
|
65.3%
83rd
|
| Debt / EBITDA | 4.55
50th
|
4.30
17th
|
5.29
75th
|
| Net debt / EBITDA | 4.54
50th
|
4.23
8th
|
5.23
75th
|
| Interest coverage (EBIT / interest) | 3.3x
83rd
|
3.4x
92nd
|
3.0x
58th
|
| Cash interest coverage | 4.5x
67th
|
4.2x
42nd
|
4.3x
50th
|
| Debt payback (years of OCF) | 6.7 yrs
58th
|
6.0 yrs
33rd
|
5.6 yrs
17th
|
| Liabilities / assets | 71.4%
92nd
|
43.2%
17th
|
68.7%
83rd
|
| IS credit model rating | B+ | BBB | BB+ |
| Implied credit spread (bps) | 650
75th
|
275
25th
|
400
42nd
|
Efficiency
11 measures| Measure | UDR | AMH | ELS |
|---|---|---|---|
| Asset turnover | 0.16
67th
|
0.14
33rd
|
0.28
100th
|
| Fixed asset turnover | 0.19
57th
|
0.16
14th
|
— |
| Inventory turnover | — | — | — |
| Receivables turnover | 10.9
22nd
|
39.2
89th
|
24.2
56th
|
| Days sales outstanding | 34 days
83rd
|
9 days
33rd
|
15 days
58th
|
| Days inventory outstanding | — | — | — |
| Days payables outstanding | 57 days
75th
|
0 days
33rd
|
35 days
58th
|
| Cash conversion cycle (days) | −23 days
36th
|
9 days
73rd
|
−20 days
45th
|
| Capex / revenue | — | — | 4.2%
30th
|
| Capex / depreciation | — | — | 0.31
67th
|
| Operating expense ratio | 44.7%
50th
|
31.8%
12th
|
61.1%
75th
|
Cash flow & earnings quality
7 measures| Measure | UDR | AMH | ELS |
|---|---|---|---|
| Operating cash flow / net income | 1.71
11th
|
1.81
22nd
|
1.46
0th
|
| FCF / net income | 1.76
44th
|
1.94
56th
|
1.30
11th
|
| FCF / operating cash flow | — | — | 88.8%
60th
|
| Capex / operating cash flow | — | — | 11.2%
40th
|
| Accruals ratio | -3.5%
75th
|
-2.9%
100th
|
-3.2%
83rd
|
| Sloan accruals ratio | -12.9%
8th
|
-1.7%
58th
|
4.4%
92nd
|
| Earnings quality score (0-1) | 1.00
44th
|
1.00
44th
|
1.00
44th
|
Scores & forensic checks
15 measures| Measure | UDR | AMH | ELS |
|---|---|---|---|
| IS score | 56
75th
|
56
67th
|
67
92nd
|
| IS profitability | 64
83rd
|
62
75th
|
85
100th
|
| IS growth | 58
75th
|
51
42nd
|
55
50th
|
| IS value | 49
50th
|
53
58th
|
41
17th
|
| IS momentum | 86
75th
|
80
50th
|
81
58th
|
| IS risk (safety) | 15
0th
|
30
42nd
|
50
100th
|
| IS quality | 70
58th
|
81
92nd
|
77
83rd
|
| IS balance sheet | 23
8th
|
48
92nd
|
25
17th
|
| IS earnings quality | 83
42nd
|
92
92nd
|
92
83rd
|
| IS cash flow | 86
92nd
|
86
83rd
|
85
75th
|
| Piotroski F-score (0-9) | 7
67th
|
8
100th
|
7
67th
|
| Altman Z-score | 0.7
8th
|
1.6
75th
|
2.4
100th
|
| Beneish M-score | −3.14
64th
|
−3.13
73rd
|
−3.42
45th
|
| Ohlson O-score | −6.39
83rd
|
−8.58
8th
|
−6.50
75th
|
| IS credit score | 35
25th
|
60
75th
|
50
58th
|
Size (TTM)
8 measures| Measure | UDR | AMH | ELS |
|---|---|---|---|
| Market cap | $11.0B
50th
|
$11.2B
58th
|
$11.9B
67th
|
| Revenue | $1.7B
58th
|
$1.9B
67th
|
$1.6B
50th
|
| EBITDA | $1.3B
92nd
|
$1.2B
67th
|
$626.6M
33rd
|
| Net income | $522.2M
92nd
|
$478.5M
83rd
|
$401.8M
50th
|
| Free cash flow | $921.6M
67th
|
$926.4M
75th
|
$522.7M
33rd
|
| Total assets | $10.3B
58th
|
$13.1B
92nd
|
$5.8B
25th
|
| Shareholders' equity | $2.9B
33rd
|
$6.8B
92nd
|
$1.8B
25th
|
| Employees | 1,420
42nd
|
1,598
50th
|
3,700
100th
|
Price performance
9 measures| Measure | UDR | AMH | ELS |
|---|---|---|---|
| 1 day | +0.1% | +1.0% | +1.6% |
| 1 week | +0.3% | +1.4% | +3.7% |
| 1 month | +0.1% | +0.0% | +1.1% |
| 3 months | −13.8% | −7.2% | −5.3% |
| 6 months | −3.0% | +2.0% | −4.7% |
| Year to date | −5.6% | −2.0% | +5.1% |
| 1 year | −5.5% | −3.0% | +1.9% |
| 3 years, cumulative | +1.4% | −4.6% | +2.9% |
| 5 years, cumulative | −24.4% | −8.4% | −11.9% |
Technicals
4 measures| Measure | UDR | AMH | ELS |
|---|---|---|---|
| RSI 14 | 47.3 | 53.2 | 60.9 |
| From 52-week high | −18.2% | −10.8% | −8.9% |
| From 52-week low | +4.0% | +14.9% | +7.5% |
| Beta | 0.71 | 0.79 | 0.64 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17